<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-9VDTEWIM</identifier><date>2009</date><creator>Ostanek, Barbara</creator><relation>documents/doc/9/URN_NBN_SI_doc-9VDTEWIM_001.htm</relation><relation>documents/doc/9/URN_NBN_SI_doc-9VDTEWIM_001.pdf</relation><relation>documents/doc/9/URN_NBN_SI_doc-9VDTEWIM_001.txt</relation><format format_type="issue">1</format><format format_type="volume">60</format><format format_type="type">article</format><format format_type="extent">str. 3-7</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">2539633</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-9VDTEWIM</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">drug</subject><subject language_type_id="slv">Gilbertov sindrom</subject><subject language_type_id="slv">hiperbilirubinemija</subject><subject language_type_id="slv">polimorfizem</subject><subject language_type_id="slv">toksičnost</subject><subject language_type_id="slv">zdravila</subject><title>Genetics and pharmacogenetics of Gilbert's syndrome</title><title>Genetika in farmakogenetika Gilbertovega sindroma</title></Record>